MedTrace Logo

Cabergoline Before or After Oocyte Collection for Follicular Resolution

NCT04096027 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-06-14

No results posted yet for this study

Summary

Randomized trial comparing the efficacy of two different times of administration of cabergoline in patients undergoing controlled ovarian stimulation and oocyte collection.

Conditions

  • Infertility, Female

Interventions

DRUG

Cabergoline Pill

0.5 mg cabergoline pill taken orally

Sponsors & Collaborators

  • Fertility Center of Las Vegas

    lead INDUSTRY

Principal Investigators

  • Bruce Shapiro, MD · Fertility Center of Las Vehas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2021-06-10
Completion
2021-06-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04096027 on ClinicalTrials.gov